Pharmafile Logo
Pharmafocus logo
Advanced Search

New study reveals the range of co-morbidities faced by patients with type 2 diabetes

August 24, 2022
Research and Development

A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, …

News

Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox

August 24, 2022
Research and Development

The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …

News

Paediatric Investigation Plan approved by MHRA

August 24, 2022
Research and Development

Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …

News

Togo becomes first country to eliminate four neglected tropical diseases

August 24, 2022
Research and Development

WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …

News

Open Orphan signs £10.4 million contract with global pharma client

August 23, 2022
Manufacturing and Production

Open Orphan has announced that its subsidiary hVIVO has signed a £10.4 million contract with an unnamed major global pharmaceutical …

News

UK to offer mini dose of monkeypox jab amid low stocks

August 23, 2022
Manufacturing and Production

Three NHS sites will begin a pilot offering eligible patients smaller doses of monkeypox vaccine, following global shortages of the …

News

Initiative to improve next generation cancer diagnostics

August 23, 2022
Manufacturing and Production

The Medical Device Innovation Consortium (MDIC) has formally launched its Somatic Reference Samples (SRS) Initiative with a pilot project, aiming …

News

Dengue vaccine approved in Indonesia regardless of prior exposure

August 23, 2022
Manufacturing and Production

Takeda have announced the dengue vaccine, QDENGA®, was approved by the Indonesia National Agency for Drug and Food Control. Dengue …

News

Approval of only twice-yearly HIV treatment option

August 22, 2022
Sales and Marketing

The European Commission (EC) has granted a Marketing Authorisation for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV …

News

NICE issues positive appraisal document for combination treatment for advanced kidney cancer

August 22, 2022
Sales and Marketing

NICE has published an appraisal consultation document (ACD) recommending the use of lenvatinib as a therapeutic option for untreated intermediate …

News

EMA accept marketing authorisation application for invasive candidiasis treatment

August 22, 2022
Sales and Marketing

The EMA has accepted the marketing authorisation application (MAA) for rezafungin, for the treatment of invasive candidiasis in adult patients. …

News

New WHO recommendations for Ebola treatments and improved access

August 22, 2022
Sales and Marketing

WHO has published its first guideline for Ebola virus disease therapeutics, calling on the global community to increase access to …

News
mosquito-g4c5e34fdf_1280

GSK awarded UNICEF contract for malaria vaccine

August 19, 2022
Medical Communications

In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per …

News

New COVID-19 study from The Lancet Psychiatry journal shows higher risk of brain fog

August 19, 2022
Medical Communications

The study also found that adults faced an increased risk of anxiety and depression, but this subsided within two months …

News
abstract-g7ff383c53_1920

Home-based brain stimulation study on stroke survivors finds mixed results

August 19, 2022
Medical Communications

26 stroke survivors were given four weeks of remotely supervised transcranial direct current stimulation (RS-tDCS) in an at-home cognitive rehabilitation …

News

Jazz Pharmaceuticals takes groundbreaking epilepsy drug Epidiolex for adolescents into phase III trial

August 19, 2022
Medical Communications

The phase III trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged …

News

GSK’s new drug application for momelotinib accepted by FDA

August 18, 2022
Business Services

The potential drug treatment is for myelofibrosis patients with anaemia UK-based GSK has announced that the US Food and Drug …

News
asthma-938695_960_720

NHS Scotland recommends Chiesi’s Trimbow for asthma

August 18, 2022
Business Services

In the UK, 5.4 million people are currently receiving treatment for asthma Chiesi Limited has announced that the Scottish Medicines …

News
cold-3835499_960_720

Newly discovered peptide shows promising results in preventing seizures; a potential future treatment for epilepsy and Alzheimer’s

August 18, 2022
Business Services

A study published in The American Society for Clinical Investigation highlights developments made by researchers to develop A1R-CT, a peptide …

News
eeg

New method involving musical tests can enable early detection of cognitive decline

August 18, 2022
Business Services

Researchers at Tel Aviv University have created a method which uses musical tests and a portable brain activity-measuring device to …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026